BDBM50212027 4-(4-bromophenyl)-2-(4-(2-hydroxyethyl)phenylamino)pyrimidine-5-carbonitrile::CHEMBL234067

SMILES OCCc1ccc(Nc2ncc(C#N)c(n2)-c2ccc(Br)cc2)cc1

InChI Key InChIKey=JXYOUGHKVXLLSK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50212027   

TargetCyclin-dependent kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50212027(4-(4-bromophenyl)-2-(4-(2-hydroxyethyl)phenylamino...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of CDK1 activityMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50212027(4-(4-bromophenyl)-2-(4-(2-hydroxyethyl)phenylamino...)
Affinity DataIC50: 180nMAssay Description:Inhibition of VEGFR2 activityMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed